Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

best hospitals for women

Women’s org names best hospitals for women

The Women’s Choice Award is out with its 2024 lists of best hospitals for women across 19 categories, from bariatrics and cancer care to stroke care and women’s services.

class i recall bronchoscopes

Popular bronchial scopes slapped with Class I recall

More than 17,000 medical devices used to diagnose and treat the lungs and airways are being recalled.

UCL Imaging vest screening cardiac conditions

New vest developed by cardiologists uses advanced heart imaging to screen for sudden cardiac arrest

“We identified a problem in cardiology,” one cardiologist explained. “Heart imaging has made remarkable progress in recent decades, but the electrics of the heart have eluded us."

Thumbnail

Balloon-expandable TAVR valves linked to superior 1-year outcomes

Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective. 

hospital digital health strategy

Hospital C-suites increasingly perceive need for digital health mission, vision

More than two-thirds of hospital executives, 70%, say their institution has a formal or comprehensive strategy in place for selecting, acquiring and integrating digital health products.

Newsweek ranked the 50 best heart hospitals in the world

Hybrid coronary revascularization vs. CABG for multivessel CAD: New meta-analysis tracks long-term outcomes

A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes. 

HeartMate 3 LVAD abbott

Former FDA employees share concerns about heart device safety data

Abbott's HeartMate 3 LVAD is the only FDA-approved device of its kind currently available in the United States. Should reports of adverse events worry cardiologists? Or are they to be expected when treating such a vulnerable patient population?

business launch

‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.